Profound Medical Corp. (PROF)
↓ Download CSV- Sector Manufacturing
- Incorporated A6
- Fiscal year ends Dec 31
In fiscal 2025, Profound Medical Corp. reported revenue of $16.10M, up 50.7% from the prior year. The company ran a net loss, with a net margin of -264.4% and a gross margin of 70.8%. It held $77.47M in total assets against $11.04M in total liabilities.
Key ratios (FY2025)
70.8%
Gross margin
-256.3%
Operating margin
-264.4%
Net margin
-64.1%
Return on equity
+50.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $16.10M | $10.68M | $7.20M | — |
| Cost of Revenue | $4.71M | $3.64M | $2.89M | — |
| Gross Profit | $11.39M | $7.04M | $4.31M | — |
| Operating Income | -$41.25M | -$33.06M | -$28.65M | — |
| Net Income | -$42.57M | -$27.82M | -$28.32M | — |
| EPS (Diluted) | $1.41 | $1.12 | $1.34 | — |
| Total Assets | $77.47M | $70.23M | $43.96M | — |
| Total Liabilities | $11.04M | $9.81M | $12.73M | — |
| Shareholders' Equity | $66.43M | $60.42M | $31.22M | $52.60M |
| Cash & Equivalents | $59.72M | $54.91M | $26.21M | — |
| Operating Cash Flow | -$38.21M | -$23.45M | -$22.61M | — |
| Capital Expenditures | $176.0K | — | — | — |
| Shares Outstanding | 36.29M | 30.04M | 21.37M | — |